Furosemide Inhalation in Dyspnea of Mustard Gas Exposed Patients

Phase 3CompletedNCT00512811

Baqiyatallah Medical Sciences University

Overview

to assess the efficacy of inhaled furosemide in mustard gas exposed patients with acute respiratory failure

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

SUPPORTIVE_CARE

Masking

QUADRUPLE

Conditions

Bronchiolitis

Interventions

furosemideDRUG

Eligibility

Sex: MALEMin age: 32 YearsMax age: 83 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patients with a history of exposure to sulfur mustard with a complaint of dyspnea Exclusion Criteria: * A contraindication for furosemide use; * An accompanying disease in which other drugs effective for dyspnea were used

Locations (1)

RCCI

Tehran, Tehran Province, Iran

Outcomes

Primary Outcomes

effect of furosemid inhalation on dyspnea

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.